Back to contents

Key PrEP studies

A wide range of results have been reported in other PrEP studies, with some finding high effectiveness and some none at all.

Click on the table to see a larger version.

For more information on these studies, click on the following links:

CAPRISA 004, iPrEx, FEM-PrEP, Partners PrEP, TDF-2, VOICE, Bangkok tenofovir study, FACTS 001, IPERGAY, PROUD

PrEP

Published July 2015

Last reviewed July 2015

Next review July 2018

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.